2018
DOI: 10.1016/j.cellimm.2018.07.007
|View full text |Cite
|
Sign up to set email alerts
|

Glycans as critical regulators of gut immunity in homeostasis and disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
19
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 30 publications
(22 citation statements)
references
References 164 publications
1
19
0
Order By: Relevance
“…8,27,[29][30][31] Alterations in these processes can lead to autoimmune diseases and cancer. 5,32 It is not clear whether alterations in cell glycosylation profiles occur as an early event (inducing) or late event (accelerating) in intestinal inflammation. Intestinal T cells from patients with IBD have glycome profiles that differ from those individuals without IBD, characterized by decreased levels of branched N-glycans 19,30 and increased levels of core fucosylation (the addition of a fucose residue to the core structure of N-linked glycans with an a1,6 linkage).…”
Section: Glycosylation In T Cellsmentioning
confidence: 99%
See 1 more Smart Citation
“…8,27,[29][30][31] Alterations in these processes can lead to autoimmune diseases and cancer. 5,32 It is not clear whether alterations in cell glycosylation profiles occur as an early event (inducing) or late event (accelerating) in intestinal inflammation. Intestinal T cells from patients with IBD have glycome profiles that differ from those individuals without IBD, characterized by decreased levels of branched N-glycans 19,30 and increased levels of core fucosylation (the addition of a fucose residue to the core structure of N-linked glycans with an a1,6 linkage).…”
Section: Glycosylation In T Cellsmentioning
confidence: 99%
“…61,62 Accordingly, mice models lacking core 1 and core 3derived mucin type O-glycans develop spontaneous colitisassociated cancer. 32,63 Overexpression of b1,6 branching N-glycosylation has been associated with malignancy, 64 cell invasiveness, 18,[65][66][67] and reduced survival times of patients with cancer 68 ( Figure 1). Aberrant expression of branched glycans can affect regulation of immune response, although little is known about its effects in patients with IBD-associated CRC.…”
Section: Glycosylation Alterations In Inflammation-associated Gastroimentioning
confidence: 99%
“…Additionally, glycans can also restrict nonspecific protein-protein interactions, like aggregation of TCRs on the membrane, helping to orient the interactions of the proteins in the central clusters ( 31 ). Demetriou et al demonstrated that β1,6-GlcNAc branched N- glycans structures (catalyzed by GnT-V) regulate T cell activity, namely in CD4 + T cells by increasing the threshold of T cell activation, suppressing T cell growth and signaling ( 30 , 42 ). Moreover, core-fucosylation, which refers to fucose attached to the innermost N- acetylglucosamine of N- linked glycans, catalyzed by α1-6 fucosyltransferase (FUT8), was also shown to affect T cell activity in immune mediated disorders ( 42 , 43 ).…”
Section: Glycans In the Regulation Of T Cell Activity And Functionsmentioning
confidence: 99%
“…Glycans are a source of carbon for microbes, and are crucial to recognition, signalling, and epigenetic regulation between host cells and microbes, which implicates them in a range of immunological and metabolic disorders [5]. Developing interventions and therapeutics that target glycan expression by hosts or microbes is complicated by their diversity and complexity, and hindered by a poor understanding of structure function specificity of both glycan motifs and enzyme cohorts employed by microbes [6,7].…”
Section: Glycans: Sources Structures and Functionsmentioning
confidence: 99%